Pharma-Bio Serv (PBSV) Assets Average (2011 - 2026)

Pharma-Bio Serv's Assets Average history runs 14 years deep, the most recent figure standing at $12.5 million for Q2 2026.

• Quarterly Assets Average fell 16.45% year-over-year to $12.5 million in Q2 2026, while the trailing twelve-month figure through Apr 2026 was $12.5 million (down 16.45% YoY) and the FY2025 annual result came in at $15.0 million, down 17.27% from the prior year.
• Assets Average was $12.5 million for Q2 2026 at Pharma-Bio Serv, down from $13.6 million in the prior quarter.
• Across five years, Assets Average topped out at $23.0 million in Q1 2022 and bottomed at $12.5 million in Q2 2026.
• A 5-year average of $18.0 million and a median of $18.8 million in 2024 frame the typical range for Assets Average.
• Annual changes were most pronounced in 2022 — Assets Average slipped 28.33% — and 2023, when it increased 0.67%.
• Pharma-Bio Serv's Assets Average stood at $20.5 million in 2022, then slipped by 1.91% to $20.1 million in 2023, then dropped by 18.88% to $16.3 million in 2024, then retreated by 16.47% to $13.6 million in 2025, then slipped by 8.04% to $12.5 million in 2026.
• Business Quant data shows PBSV's Assets Average at $12.5 million in Q2 2026, $13.6 million in Q1 2026, and $13.6 million in Q4 2025.